Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
CDMO
Sort By
Newest First
1 / 41
1 / 41
Pancreatic
PCI Pharma Services and ChiRhoClin Partner to Prevent Shortage of Critical Orphan Pancreatic Drug
PCI Pharma Services
PR-11-24-NI-114
Nov 19, 2024
Precision Medicine
Advancing Personalized Medicines and Precision Therapeutics
Thermo Fisher Scientific
PAO-11-24-RTM-10
Nov 15, 2024
Biotherapeutics
Building on Australia's Existing Biopharma Infrastructure
BIoCina
PAO-11-24-RTM-07
Nov 15, 2024
CDMO
Supporting Oral Solid Development in Australia and Beyond
Grant Swart
Mayne Pharma Services
PAO-11-24-RTM-02
Nov 12, 2024
Gene Therapy
Genezen Welcomes Industry Experts Dr. Pam Stetkiewicz and Stuart Auerbach to Board of Directors
Genezen
PR-10-24-NI-90
Nov 11, 2024
Clinical Trials
One of Our First Looks at the Burgeoning Australia Biotech Ecosystem
PCI Pharma Services
PAO-10-24-RTM-04
Nov 04, 2024
PPQ
Fast Path to Market: Going from GMP1 to PPQ in Just 12 Months
Jessica Feldman, Ph.D.; Henning Gerschewski
Rentschler Biopharma SE
PAO-10-24-CL-12
Nov 04, 2024
QbD
Designing Quality into Biomanufacturing
Miguel Carrion; Michelle Kneeland
Tanvex CDMO
PAO-10-24-CL-09
Oct 29, 2024
Advanced Therapies
A New Vision for Progressing Advanced Therapies
Nathaniel Youndt
ReciBioPharm
PAO-10-24-CL-13
Oct 25, 2024
Financing
Samsung Biologics reports third quarter 2024 financial results
Samsung Biologics
PR-10-24-NI-58
Oct 23, 2024
CDMO
Mikart Adds Nitrogen-Purged Capability to Liquid and Suspension Suites
Mikart
PR-10-24-NI-54
Oct 22, 2024
Lyophilization
Pioneering Innovation in Pharmaceutical Lyophilization
Thermo Fisher Scientific
PAO-10-24-CL-05
Oct 22, 2024
Appointment
Bio X Cell Announces Board of Director Appointments
Bio X Cell
PR-10-24-NI-45
Oct 17, 2024
CDMO
Samsung Biologics launches high-concentration formulation platform to accelerate high-dose drug development
Samsung Biologics
PR-10-24-NI-41
Oct 14, 2024
CDMO
Revolutionary CDMO Wheeler Bio Appoints Patrick Lucy as CEO
David Alvaro, Ph.D.
Pharma's Almanac
PAO-10-24-CL-08
Oct 11, 2024
Announcement
Genezen Appoints Mike Wourms as Chief Operations Officer
Genezen
PR-10-24-NI-36
Oct 08, 2024
CDMO
Innovating and Collaborating to Support Biopharma Beyond the Typical CDMO
Janet Hoogstraate, Ph.D.
NorthX Biologics
PAO-10-24-CL-07
Oct 07, 2024
RNA
Optimized Residual dsRNA Detection for mRNA Therapeutics
Eunseo (Ency) Lee, Ph.D; Namhyun Kim; Hwanjun Yoon, Ph.D.; Sukhwan Kim; Ahyeon Hwang
Samsung Biologics
PAO-09-24-CL-07
Sep 30, 2024
Bioassays
Developing a Toolbox of Functional Bioassays for Optimizing ADCC
Anke Hartung, Ph.D.,
Tanvex CDMO
PAO-09-24-CL-09
Sep 30, 2024
Financing
CPhI WW, Olon Will Attend with a Stronger Market Position after the Two International Acquisitions
Olon
PR-09-24-NI-23
Sep 30, 2024
